Investment Opportunities in the GCC and UAE Diabetes Devices Market (2025–2030)

0
68

The GCC and UAE diabetes devices market size was valued at USD 3.12 billion in 2024 and is expected to grow at a CAGR of 7.3% from 2025 to 2030. The market growth is primarily driven by the rising incidence of diabetes, the increasing adoption of advanced technologies for managing fluctuating blood glucose levels, and the growing use of telehealth services following the COVID-19 pandemic. In addition, greater awareness of diabetes preventive care and strong government initiatives continue to support market expansion.

For instance, the Saudi Arabian government has set ambitious public health goals, including achieving a 0% rise in diabetes-related mortality by 2025 and a 10% reduction in overall diabetes incidence by 2030.

Diabetes remains a major public health challenge across the Middle East, driven largely by unhealthy lifestyle patterns and associated risk factors such as obesity and physical inactivity. According to the International Diabetes Federation (IDF), the number of people living with diabetes in the UAE is expected to increase from 0.99 million in 2021 to 1.32 million by 2045. This growing disease burden underscores the importance of early prevention and effective management strategies.

To address these challenges, the Ministry of Health and Prevention (MoHAP) launched several key initiatives. In 2020, the ministry introduced a drive-in awareness campaign aimed at improving the quality of life for individuals living with diabetes. Furthermore, the Diabetes Prevention Program was established to provide education and training focused on healthy lifestyle practices, reinforcing the UAE government’s commitment to combating diabetes at both preventive and community health levels.

Key Market Trends & Insights:

• In 2024, Saudi Arabia emerged as the dominant country in the GCC and UAE diabetes devices market, accounting for the largest revenue share of 28.9%. This strong market position can be attributed to the high prevalence of diabetes, increased healthcare expenditure, and growing government focus on diabetes management programs. Additionally, the expansion of healthcare infrastructure and the introduction of advanced diabetes care technologies further strengthened Saudi Arabia’s leadership in the regional market.

• The diabetes devices market in the UAE is anticipated to grow at a robust CAGR of 8.1% over the forecast period. This growth is driven by rising awareness of diabetes management, increasing adoption of digital and wearable glucose monitoring devices, and government initiatives aimed at improving access to preventive healthcare services. The country’s growing elderly population and changing lifestyle patterns are also contributing significantly to the increased demand for diabetes management devices.

• By services, the pharmaceutical, drugs, and supplies segment led the market, capturing the largest share of 39.5% in 2024. This dominance is primarily due to the high consumption of insulin, oral anti-diabetic drugs, and other diabetes-related medical supplies required for long-term disease management. The growing emphasis on combination therapies and continuous advancements in insulin formulations have further supported the growth of this segment.

• In terms of distribution channel, the hospital pharmacies segment held the leading position in 2024, accounting for the highest revenue share of 55.3%. The dominance of this segment can be attributed to the widespread availability of diabetes care products in hospitals, the trust associated with hospital-based prescriptions, and the increasing number of patients seeking regular checkups and treatments through hospital networks.

• By end-use, the hospital segment continued to dominate the GCC and UAE diabetes devices industry, accounting for the largest revenue share of 42.4% in 2024. Hospitals serve as the primary centers for diagnosis, treatment, and long-term monitoring of diabetes patients. The growing number of hospital admissions for diabetes-related complications and the availability of comprehensive diabetes care programs have further contributed to the strong performance of this segment.

Order a free sample PDF of the GCC And UAE Diabetes Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 3.12 Billion

• 2030 Projected Market Size: USD 4.73 Billion

• CAGR (2025-2030): 7.3%

Key Companies & Market Share Insights:

Key players in the GCC and UAE diabetes devices industry include major companies such as Medtronic, Abbott Laboratories, Ascensia Diabetes Care Holdings, and several other notable market participants. These companies play a crucial role in driving innovation and advancing diabetes management technologies across the region. To strengthen their market position, they are actively engaging in a range of strategic initiatives, including mergers and acquisitions, geographical expansions, new product launches, government approvals, and collaborative partnerships. Such strategies enable these players to broaden their product portfolios, enhance distribution networks, and address the rising demand for advanced diabetes care solutions in the GCC and UAE.

Dexcom is a key company specializing in the development and manufacturing of continuous glucose monitoring (CGM) systems, including its widely recognized G6 and G7 models. These systems provide real-time glucose readings, enabling better diabetes management through continuous tracking and early detection of glucose fluctuations. Dexcom’s CGM devices are designed for both personal and professional use, catering to insulin-dependent patients as well as individuals at risk of hypoglycemia. By offering accurate and user-friendly glucose monitoring technology, Dexcom contributes significantly to improving patient outcomes and supporting healthcare professionals in managing type 1 and type 2 diabetes effectively.

Sanofi operates in the pharmaceutical segment of the diabetes market and is widely recognized for developing and distributing a broad range of diabetes medications, including insulin and oral antidiabetic drugs. The company’s therapeutic solutions are aimed at effectively managing blood glucose levels and minimizing diabetes-related complications. Sanofi’s product offerings complement device-based diabetes management systems by providing comprehensive treatment options, thereby enabling holistic care for individuals with various types of diabetes. Through continuous innovation and partnerships, Sanofi remains committed to advancing diabetes treatment and improving access to quality medications across the GCC and UAE.

Key Players

• Medtronic

• Abbot Laboratories

• Ascensia Diabetes Care Holdings

• Dexcom

• F. Hoffmann- La Roche AG,

• Sanofi

• Novo Nordisk A/S

• Insulet Corporation

• Ypsomed AG

• Eli Lily

• Astra Zeneca

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The diabetes-devices market in the GCC and UAE is poised for robust expansion over the coming years, driven by a rising diabetes burden, increased uptake of advanced monitoring and management technologies, and supportive government programmes. Key service segments (such as drugs, supplies and devices) and hospital-based channels dominate today, while home-care and online-distribution channels are set to gain momentum as the guest-health infrastructure evolves. 

Αναζήτηση
Κατηγορίες
Διαβάζω περισσότερα
Party
Cây Mai Tứ Quý: Tượng Trưng Cho Sự Thịnh Vượng và Phong Thủy Độc Đáo
Cây mai tứ quý, một loại cây đặc biệt với khả năng nở hoa hai lần trong năm,...
από hvttalatathui 2023-10-17 06:42:13 0 9χλμ.
άλλο
Electronics Recycling Market is Expected to Reach a Valuation of US$ 120 Bn by 2033
According to Fact.MR, a market research and competitive intelligence company, the...
από nainad 2025-08-07 10:08:10 0 446
Παιχνίδια
RP Exchange: India’s Leading Provider of Cricket Online IDs
The online betting industry in India has witnessed tremendous growth over the past few years,...
από rpexchange 2025-10-11 07:33:40 0 112
Παιχνίδια
Buy Cheap EA FC 25 Coins for Sale: Unlock Your Ultimate Team Potential!
Buy Cheap EA FC 25 Coins for Sale: Unlock Your Ultimate Team Potential! In the exhilarating...
από Casey 2025-04-02 02:54:04 0 1χλμ.
Παιχνίδια
**¿Dónde y Cómo Comprar Currency en POE 2: Guía Completa sobre Poe Quecholli y Otras Opciones?**
¿Dónde y Cómo Comprar Currency en POE 2: Guía Completa sobre Poe...
από Casey 2025-06-06 20:04:56 0 1χλμ.